The Clinical Research Unit (UIC) will allow clinical trials of medicines to be carried out on patients, from the most experimental phase to the final stage when their use is authorized
The Secretary of State for Science, Innovation and Universities, Juan Cruz Cigudosa, visited the facilities of the Pere Virgili Health Research Institute (IISPV), located in the Sant Joan University Hospital in Reus. The purpose of the visit was to learn about the development of the new Clinical Research Unit (UIC), a facility that will make it possible to carry out clinical trials with medicines on local patients in all phases—from phase 1, the most experimental, to phase 4, the final stage after which the medicine is approved for use. The CRU will occupy 500 m² and will be located inside the Sant Joan University Hospital in Reus. Its construction is supported by €4,300,000 in funding from the Carlos III Health Institute, the leading biomedical research organization under the Ministry of Science, Innovation and Universities.
During the visit, the Secretary of State was accompanied by the Government’s Deputy Representative in Tarragona, Elisabet Romero; the Mayor of Reus, Sandra Guaita; the City Councillor for Economic Promotion and Knowledge, Josep Baiges; the President of the IISPV Governing Board and Director of Health Services in Tarragona, Marta Milà; and other members of the IISPV Governing Board. Juan Cruz Cigudosa emphasized that this is an important project that will become a reference point for clinical research in southern Catalonia. He also highlighted the importance of giving hospitals across the region access to this kind of infrastructure. In addition, he pointed out that “this is one of the highest-rated projects in a national funding call worth €45 million. This new unit has received almost 10% of the total budget available in that call, which was open to projects from all over Spain.”
The Mayor of Reus, Sandra Guaita, added that “the amount of funding provided by the State shows that this is a strong project that will have a direct impact on citizens, as it will allow more equal access to medicines—something that used to happen only in large cities.” In the same vein, the Director of IISPV, Joan Vendrell, explained that “this Clinical Research Unit will serve the entire province and benefit 850,000 people, from university hospitals to regional hospitals in different health areas.” He also said: “We would even like pharmacies to help share information about the studies being carried out, so that people can learn about them and, if they wish, take part.”
Since the funding was announced in early 2025, the tendering process for the construction work has already started, and part of the necessary equipment has been ordered. In terms of staff, six people have already joined IISPV to work directly with the CRU: two data managers, one administrative staff member, one radiology technician, and two nurses. The unit is expected to be operational by the end of 2026.
The IISPV is organising the activity for Saturday 20 September at 12 p.m. at the Racó de la Palma in Reus, and it will be led by researchers from local research centres
On Saturday 20 September at 12 p.m., the Racó de la Palma in Reus will host the science microtalks, an activity included in the European Researchers’ Night. The goal is to bring scientific research closer to the public in a friendly, accessible and engaging way.
The event is organised by the Institut d’Investigació Sanitària Pere Virgili (IISPV), in collaboration with the Universitat Rovira i Virgili (URV) and other research centres in the region. Researchers from different fields will share, in 10-minute talks, the latest advances in health, sustainability, energy and well-being.
Topics will include the effects of microplastics on the intestine, the role of the Mediterranean diet during pregnancy, patient safety in critical situations, responsible use of antibiotics, psychiatric disorders, and key ideas for a fair and sustainable energy transition.
The speakers will be:
Celia Uroz Mas – Efectes dels microplàstics en el nostre intestí
Sergi Danés – Del sol al combustible: energia neta per a una societat sostenible
Sara Bernardo Castro – Dieta mediterrània durant l’embaràs: modelant el desenvolupament cerebral i psicològic dels fills
Ruth Tortosa Alted – La transferència de cures en malaltia crítica: un repte de seguretat del paciente
Marta Llorens Fons – Antibiòtics: manipula’ls amb cura!
Sergi Saladié Gil – Bases per a una transició energètica justa i sostenible
Elisabet Vilella Cuadrada – Trastorns psiquiàtrics: factors de risc i factors protectors
L’activitat s’adreça a un públic general, amb un format distès i accessible, i forma part del conjunt d’actes que el IISPV impulsa per fomentar la cultura científica i connectar la recerca amb la societat.
New study reveals sex- and region-specific metabolic signatures of different adiposity indices
An international study from the Institut d’Investigació Sanitària Pere Virgili (IISPV), in collaboration with the University of Ioannina (Greece), shows that not all body fat is the same. Its location in the body and its biological effects are different between women and men. The study, led by Christopher Papandreou from the Clinical and Epidemiological Neuroscience group (NeuroÈpia) was published in the journal eBioMedicine. The research analysed metabolomic data from more than 150,000 participants in the UK Biobank and confirmed the results with an independent Greek cohort of 1,127 individuals.
The study revealed striking contrasts in how fat stored in different regions of the body influences metabolism. Abdominal fat was linked to more harmful, atherogenic metabolic changes, while fat stored in the hips and thighs (gluteofemoral fat) showed more favorable metabolic profiles. These metabolic signatures were also more strongly correlated with over 25 clinical biomarkers, including cholesterol, liver enzymes, inflammatory markers, and hormone levels, than conventional measures such as body mass index or waist circumference.
The findings underscore the importance of both fat distribution and sex-specific biology in determining metabolic health. By linking detailed metabolic profiles to regional fat depots, the study provides new insights into how adiposity drives the risk of cardiometabolic disease and cancer, and highlights the potential of metabolomic biomarkers to improve early detection and prevention strategies.
Reference
Papagiannopoulos, C. K., Markozannes, G., Chalitsios, C. V., Christakoudi, S., Gunter, M. J., Dossus, L., … Papandreou C* & Tsilidis, K. K.* (2025). Sex-stratified metabolic signatures of adiposity indices and their associations with clinical biomarkers in the UK Biobank. EBioMedicine, 119.
*Shared last authorship
A study led by URV/IISPV shows that a diet rich in different plant and animal species is associated with longer life expectancy
Food biodiversity, understood as the variety of different species included in a person’s regular diet, may play a key role in preventing chronic diseases and promoting longevity. This is suggested by data from a recent study published in the journal Science of the Total Environment, led by the Food, Nutrition, Development and Mental Health Research Group (ANUT-DSM) at the Universitat Rovira i Virgili (URV) and the Institut d’Investigació Sanitària Pere Virgili (IISPV), as part of the PREDIMED project.
The study analyzed the eating habits and health parameters of more than 7,200 people aged between 60 and 80 years, all with high cardiovascular risk. Participants were followed for an average of six years. Using validated food questionnaires and advanced statistical tools, the research team assessed the number of different species consumed through a new indicator called Dietary Species Richness (DSR), which estimates the number of different plant and animal species included in a person’s usual diet. The researchers then evaluated mortality risk based on this indicator.
The results show that people who consumed a greater variety of species had a significantly lower risk of dying from any cause. Specifically, for each additional species regularly consumed, the overall mortality risk decreased by 9%, the risk of cardiovascular disease by 7%, and the risk of cancer by 8%.
According to Sangeetha Shyam, Miguel Servet researcher at IISPV and lead author of the study, “this research shows that it’s not only important what types of food we eat, but also how many different species we include in our diet. A more biodiverse diet is linked to better health and longer life.” The findings also indicate that the link between dietary biodiversity and mortality was independent of the nutritional quality of the participants’ diets. For example, not all individuals with high adherence to the Mediterranean diet had a highly diverse diet, and vice versa.
The mechanisms behind these associations are not yet fully understood, but researchers suggest that diets rich in a wide range of plant and/or animal species may provide a broader spectrum of nutrients and beneficial compounds, and may also support a healthier gut microbiota.
This study was made possible thanks to the collaboration of multiple institutions and researchers from the PREDIMED consortium. It was led by the Food, Nutrition, Development and Mental Health Research Group (ANUT-DSM) at URV, IISPV, and CIBERobn of the Instituto Carlos III.
Reference: Shyam S, Babio N, Paz-Graniel I, Martínez-González MA, Sorlí JV, Estruch R, Ros E, Tojal-Sierra L, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Riera-Mestre A, Toledo E, Ramirez-Sabio JB, Castañer O, Lamuela R, Margara-Escudero HJ, Fitó M, Salas-Salvadó J. Food biodiversity and mortality in older Mediterranean adults with high cardiovascular risk. Sci Total Environ. 2025 Jul 25;987:179807. doi: 10.1016/j.scitotenv.2025.179807. Epub 2025 Jun 4. PMID: 40472794. Link to article
Studying fatty acids after meals may provide new insights into the metabolic impact of diet and fasting
Losing weight can be challenging, especially when it requires following a strict low-calorie diet over time. A study with mice suggests that intermittent fasting—taking regular breaks from eating—can improve metabolism, even when the diet is high in fat. In fact, the benefits observed are similar to those linked to healthy eating. This study, led by the Institut d’Investigació Sanitària Pere Virgili (IISPV) and the Universitat Rovira i Virgili (URV), was published in eBiomedicine.
Although the animals did not lose weight through intermittent fasting, researchers found improvements in blood glucose control, insulin response, and lipid profile—key indicators often affected by obesity. When intermittent fasting was combined with a healthy diet, the positive metabolic effects increased, and a significant reduction in body weight was observed.
The study not only focused on blood parameters but also examined how different dietary interventions affected fat tissue and the liver. “After four weeks of intermittent fasting, obese mice showed significant protection both metabolically and in these tissues, even with a high-fat diet,” explains Dr. Victòria Ceperuelo-Mallafré, Ramón y Cajal researcher at URV and member of the DIAMET research group (Diabetes and Associated Metabolic Diseases) at IISPV – URV – CIBERDEM.
“However, switching to a balanced diet proved to be the most effective strategy for weight loss. In addition, combining intermittent fasting with a healthy diet had a synergistic effect that was especially beneficial for improving glucose tolerance,” adds Dr. Sonia Fernández-Veledo, head of the Metabolic Diseases and Nutrition Area at IISPV and leader of the DIAMET research group.
Another innovative part of the study was the analysis of gut microbiota and its key products, especially short-chain fatty acids. These molecules, found in blood and stool, may play an important role in regulating the body’s metabolic processes. The results showed that combining intermittent fasting with a healthy diet led to deeper changes in the composition of gut microbiota. Specifically, there was an increase in the species Alistipes finegoldii, which may be linked to better blood glucose regulation. This finding was confirmed both in the animal model and in a group of people with obesity who followed a low-calorie Mediterranean diet for six months. Although the results are promising, further studies are needed to confirm this connection.
Regarding short-chain fatty acids, researchers found that their post-meal regulation is altered in obesity. Both intermittent fasting and switching to a healthy diet help restore this mechanism. Therefore, measuring these compounds not only during fasting but also after eating may offer valuable information for a better understanding of metabolic function.
Although the findings are still preliminary and more human studies are needed, this research opens the door to designing personalized dietary strategies that focus on improving metabolic health, beyond simply losing weight.
Bibliographic reference
Ceperuelo-Mallafré, V., Rodríguez-Peña, M. M., Badia, J., Villanueva-Carmona, T., Cedó, L., Marsal-Beltran, A., … & Vendrell, J. (2025). Dietary switch and intermittent fasting ameliorate the disrupted postprandial short-chain fatty acid response in diet-induced obese mice. EBioMedicine, 117.
A study led by URV also concludes that there is still insufficient evidence to confirm that this diet improves the outcomes of assisted reproductive treatments
Infertility affects one in six adults worldwide and has been recognized by the World Health Organization (WHO) as a public health issue. Several studies conducted on men in developed countries have raised concerns about a decline in semen quality, potentially linked to unhealthy lifestyle habits. Stress, smoking, alcohol consumption, drug use, and poor dietary choices are among the main risk factors associated with reduced sperm quality.
The analysis encompassed 11 original studies involving a total of 2,558 men, examining the association between adherence to the Mediterranean diet—rich in fruits, vegetables, olive oil, fish, nuts, and whole grains—semen quality, and/or various fertility parameters.
The findings revealed that men who closely followed this dietary pattern had a higher sperm count, with improved total and progressive motility, as well as a greater proportion of sperm with normal morphology. These results were observed both in healthy individuals and in patients attending fertility clinics.
However, the authors caution that, although semen quality was superior among participants with greater adherence to the Mediterranean diet, there is still no conclusive evidence that this diet directly enhances outcomes in medically assisted reproduction.
“While the Mediterranean diet appears to have a positive effect on semen quality, further research is needed to determine its actual impact on male fertility,” the research team noted.
The study’s findings form part of Rashmi Agarwal’s doctoral thesis, supervised by Albert Salas-Huetos, lecturer at URV; Nancy Babio, associate professor at the university; and Jordi Salas-Salvadó, professor and head of the Food, Nutrition, Development and Mental Health research group at URV, the Institut Sanitari Pere Virgili (IISPV), and CIBERobn at the Instituto de Salud Carlos III.
Bibliographic reference: Agarwal R, Salas-Salvadó J, Davila-Cordova E, Shyam S, Fernàndez de la Pont M, Azurmendi M, Bavi N, and Salas-Huetos A. Mediterranean diet, semen quality and medically assisted reproductive outcomes in the male population. 2025; 100454. doi: 10.1016/j.advnut.2025.100454
The agreement foresees the cooperation of the two institutions in the celebration of acts and events that promote healthy habits among citizens.
The Mayor of Reus, Sandra Guaita, and the Director of the Institut d’Investigació Sanitària Pere Virgili (IISPV), Joan Vendrell, have signed a framework protocol to foster collaboration in the fields of healthcare, public health, and health promotion. The agreement emphasises early disease detection and the capacity for a swift and effective response to health emergencies. This is the first formal agreement between the two institutions and includes provisions for joint initiatives and projects to be developed across various departments of the Reus City Council and the IISPV. It also outlines cooperation in organising events aimed at promoting healthy lifestyles among citizens.
In terms of knowledge transfer, the protocol supports the dissemination of scientific output generated by IISPV researchers, including clinical trials, patents, partnership agreements, and the creation of start-ups. It also promotes the organisation of specialised workshops and seminars focused on talent development and employment in the health sector, with the aim of equipping professionals with skills and knowledge aligned with the evolving demands of the labour market. Another key aspect of the agreement is the promotion of research addressing specific societal and industrial challenges, as well as the establishment of strategic alliances to lead transformative sectoral and regional projects, particularly through citizen science initiatives.
The framework protocol establishes a four-year collaboration period, with the possibility of annual extensions for up to an additional four years. It also allows for amendments or termination. A monitoring committee has been created to oversee the implementation of the agreement, ensure compliance, and facilitate the development of specific actions.
The signing of this protocol reaffirms the Reus City Council’s commitment to innovation, science, and technology—a commitment that was recognised last May when Reus was awarded the title of City of Science by the Ministry of Science, Innovation and Universities. In this regard, Mayor Guaita stated: “Science, research, and innovation must be at the heart of public policy as drivers of regional development. This is a key priority in our 2023–2027 Municipal Action Plan. Public administration must foster knowledge generation and management, professional training, and talent attraction, strategically rooted in the local context. This commitment can only be realised through active collaboration with the business community, scientific and academic institutions, and public authorities.
The signing of this protocol also coincides with the 20th anniversary of the IISPV, celebrated throughout 2025. According to the institute’s director, “It is vital to know that local institutions support us. Building strong ties with the region enables us to translate scientific knowledge into real solutions for patients and society. This is the core mission of our institute and the researchers who work through the IISPV”.
Levels of butyrate and isobutyrate, short-chain fatty acids produced by the intestinal microbiota, are associated with an increased risk of developing the disease, according to a study led by the IISPV and Hospital de Mar
A research team led by scientists from the Institut d’Investigació Sanitària Pere Virgili (IISPV), the Hospital de Mar Research Institute and the Diabetes and Associated Metabolic Diseases area of the CIBER (CIBERDEM), has identified two compounds present in the blood – butyrate and isobutyrate – that could act as early biomarkers of the development of type 2 diabetes in apparently healthy people. The work, published in the scientific journal BMC Medicine, is based on longitudinal analysis of more than 2,400 participants in the statewide project Di@bet.es over seven years.
These compounds are short-chain fatty acids (SCFA) produced by the fermentation of dietary fiber in the gut. “This study provides new evidence on the association between SCFA and the risk of developing type 2 diabetes,” explains Dr. Joan Vendrell, clinical coordinator of the CIBERDEM research group at IISPV and professor at the URV. “Notably, elevated levels of butyrate and isobutyrate early in the study were associated with an increased likelihood of developing type 2 diabetes, even after adjusting for traditional risk factors such as obesity, arterial hypertension or family history,” adds Dr. Gemma Llauradó, also an investigator of the study, attached to the Endocrinology and Nutrition Service of the Hospital de Mar, a researcher at her research institute.
The impact of diet on gut microbiota
The study also included an analysis of participants’ dietary patterns using a food frequency questionnaire. “Following a Mediterranean diet or consuming high-fiber foods were found to be associated with higher levels of SCFA. Even so, these habits alone did not demonstrate sufficient predictive value on the development of diabetes,” explains researcher Sonia Fernández-Veledo, head of the CIBERDEM research group at the IISPV.
The researchers stress that a diet rich in fiber continues to be fundamental for preserving the balance of the intestinal microbiota, a key factor in metabolic regulation and inflammatory response. In this sense, the work points out that SCFA could function as signaling molecules with a determining role in these physiological processes.
Towards more personalized prevention
This discovery opens the door to new, more effective and personalized prevention strategies based on the analysis of the individual metabolic and microbiotic profile. The authors of the study call for further research to better understand the interaction between these metabolites and the body, and how they can be integrated into clinical protocols for early detection of type 2 diabetes risk.
Reference article
Llauradó G, Cedó L, Climent E, Badia J, Rojo-Martínez G, Flores-Le Roux J, Yanes O, Vinaixa M, Granado-Casas M, Mauricio D, Fernández-Veledo S, Vendrell J. Circulating short-chain fatty acids and Mediterranean food patterns. A potential role for the prediction of type 2 diabetes risk: The Di@bet.es Study. BMC Med. 2025 Jun 6;23(1):337. doi: 10.1186/s12916-025-04186-9.
A diet rich in omega-3 foods during pregnancy has beneficial effects on the brain development of children and adolescents
The consumption of nuts during pregnancy, especially walnuts, benefits the neuropsychological development of children and adolescents, according to a study by the Institut d’Investigació Sanitària Pere Virgili (IISPV), titled Maternal prenatal nut and seafood consumption and child neuropsychological function from 4 to 15 years of age: a population-based cohort study, and published in The American Journal of Clinical Nutrition. The study, led by the Clinical and Epidemiological Neuroscience Research Group (NeuroÈpia) of the IISPV, includes contributions from Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, and the California Walnut Commission, and is also included in the INMA project. This observational study focuses on the influence of maternal diet during gestation, a critical period for early brain development, and also highlights adolescence as another key stage when several brain regions continue to mature.
A sample of 1,737 mother-child pairs from four Spanish regions was studied: Asturias, Guipúzcoa (Basque Country), Sabadell (Catalonia) and Valencia. Maternal diet was analyzed using a food frequency questionnaire, while the children’s neuropsychological function was assessed through standardized tests measuring reaction time and variability (attention), working memory, and fluid intelligence.
The research took into account the consumption of fish—especially fatty fish—which, like walnuts, contains high levels of omega-3 fatty acids. These healthy fats have been shown to have a positive impact on the brain development of children and adolescents, according to the study’s findings. However, the researchers leading the project caution that fatty fish consumption should be approached carefully, and the recommended portions established by the WHO, via the European Food Safety Authority (EFSA) and the Spanish Agency for Food Safety and Nutrition (AESAN), should not be exceeded. Ariadna Pinar Martí, the study’s lead researcher, notes that high consumption of walnuts and fatty fish is associated with improvements in attention, working memory, and fluid intelligence. She adds that the omega-3 fatty acids present in these foods partially contribute to this relationship with neuropsychological development, particularly regarding attention.
Impact on risky decisions
The NeuroÈpia Research Group continues to investigate how maternal consumption of nuts and fish influences the brain development of offspring. They have also focused on the acquisition of more complex skills, such as risky decision-making in eleven-year-old children. In this regard, the article Maternal nut and fish consumption during pregnancy and child risky decision-making at 11 years old explores whether a maternal diet that includes these foods is associated with certain cognitive functions and behaviors, such as impulsivity. This study, led by researcher Marina Ruiz Rivera, has been published in the European Journal of Child and Adolescent Psychiatry. It emphasizes that the consumption of nuts and fish during pregnancy may have an effect on complex brain functions, such as decision-making.
The final sample consisted of 1,386 preteenagers and their mothers, with 1,081 participants specifically assessed for decision-making. According to Ruiz Rivera, higher maternal consumption of nuts during the first trimester of pregnancy was associated with a lower score in risky decisions in eleven-year-old children. Moderate fish consumption was associated with a higher impulsivity index in children of this age. Therefore, this study “adds to the evidence on the importance of nutrition during pregnancy for complex neuropsychological functions”. The study also emphasizes that “the available data are limited to eleven years of age, a stage in which the prefrontal cortex is not fully developed”, and therefore “a definitive causal relationship cannot be established”.
Looking ahead to future research in the field of nutrition, the NeuroÈpia Research Group highlights the importance of incorporating neuroimaging techniques. Applied specifically to the cohort studied in the two projects, “it will open up new scenarios for novel measurements, represent an innovation in this field, and allow us to examine whether diet during pregnancy influences not only cognitive functions but also brain structure”, emphasizes Jordi Julvez, head of the research group behind the two studies.
Bibliographic reference of the first study:
Pinar-Martí A, Ayala-Aldana N, Ruiz-Rivera M, Lertxundi N, Subiza M, González-Safont L, Vioque J, Riaño-Galán I, Rodríguez-Dehli C, Iglesias-Vázquez L, Arija V, Fernández-Barrés S, Romaguera D, Pascual-Rubio V, Fabregat-Sanjuan A, Healy D, Basagaña X, Vrijheid M, Guxens M, Foraster M, Julvez J. Maternal prenatal nut and seafood consumption and child neuropsychological function from 4 to 15 years of age: a population-based cohort study. Am J Clin Nutr. 2025 May 5:S0002-9165(25)00249-7. doi: 10.1016/j.ajcnut.2025.04.032. Epub ahead of print. PMID: 40334748.
Bibliographic reference of the second study:
Ruiz-Rivera M, Pinar-Martí A, Babarro I, Ibarluzea J, Vioque J, Llop S, Fernández-Somoano A, Tardón A, Pascual-Vicente R, Fabregat-Sanjuan A, Fernández-Barrés S, Romaguera D, Guxens M, Julvez J. Maternal nut and fish consumption during pregnancy and child risky decision-making at 11 years old. Eur Child Adolesc Psychiatry. 2025 Jun 10. doi: 10.1007/s00787-025-02750-5. Epub ahead of print. PMID: 40493090.
A URV-IISPV-CIBEROBN study warns that 80% of children’s products are not nutritionally adequate and should not be promoted
Most foods for children under three years of age marketed in Spain are of low nutritional quality and do not meet the standards set by the World Health Organization (WHO). This is indicated by a study led by the Rovira i Virgili University (URV) together with the Pere Virgili Health Research Institute (IISPV) and the CIBER of Obesity and Nutrition (CIBEROBN), which warns that these products should not be promoted for sale.
To carry out the study, which has been published in the European Journal of Pediatrics, more than 800 products were analyzed, including purees, dairy products, snacks and beverages. The research team detected repetitive nutritional problems in these foods, such as a high content of added sugars -often in the form of concentrated juices-, low caloric intake and low energy density. In addition, many of the product labels analyzed were the result of marketing strategies that were misleading because they showed confusing product names, such as “veal with carrots”, in cases where veal was a minority ingredient. They also found food packaging with messages such as “no added sugars” and even with unscientific health claims.
“Many of these products generate a false perception of quality, when in fact they are not suitable according to WHO for the healthy development of children,” warns Paulina Maria Leszczynska, first author of the study.
“No podemos permitir que los intereses comerciales prevalezcan sobre la salud infantil. Es imprescindible contar con una normativa clara, vinculante y basada en evidencias científicas que proteja a la población más pequeña”, advierte Nancy Babio, investigadora del Departamento de Bioquímica y Biotecnología de la URV e investigadora principal del proyecto.
Stopped regulation
Currently, food advertising in Spain is governed by the PAOS Code, a voluntary self-regulation system with no sanctioning mechanisms. In 2022 the Ministry of Consumer Affairs proposed a Royal Decree to regulate the advertising of food and beverages aimed at children, using the WHO criteria as a basis, but the processing of the text is still blocked pending approval by the Council of Ministers.
In view of these facts, the research team has called on the Government to approve without further delay the Royal Decree regulating the advertising of baby food and to prohibit the promotion of products that are not suitable for children under 3 years of age, especially those with excessive sugar or misleading claims.
The work has been carried out by the dietitian-nutritionist Paulina Maria Leszczyńska and the research team of the Department of Biochemistry and Biotechnology of the URV Sara de Heras-Delgado, Sangeetha Shyam, Jordi Salas-Salvadó and Nancy Babio, which is also part of the IISPV and CIBEROBN. The study has counted with Diane Threapleton and Janet Cade, from the University of Leeds, authors of the Nutrient and Promotion Profile Model Calculator tool, used to evaluate the nutritional and promotional performance of children’s products according to the WHO model.
Bibliographic Reference: Leszczyńska PM, de Las Heras-Delgado S, Shyam S, Threapleton D, Cade J, Salas-Salvadó J, Babio N. Nutricional contento y promocionar prácticas de foods para niños y jóvenes en el español mercado: en el cross-sectional product evaluation. Eur J Pediatr. 2025 May 10;184(6):333. doi: 10.1007/s00431-025-06156-y. PMID: 40347273; PMCID: PMC12065749.
